CTMX vs VALN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CTMX · CytomX$2.19 ▲ 2.34%
VALN · Valneva$5.51 ▼ 2.31%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CTMX -47.7%
- VALN -38.0%
Head to head
| Metric | CTMX | VALN |
|---|---|---|
| Price | $2.19 | $5.51 |
| Change today | ▲ 2.34% | ▼ 2.31% |
| Market cap | $477.43M | $524.15M |
| Return, 3 months | -36.3% | +4.0% |
| Return, year to date | -48.6% | -37.5% |
| Return, 1 year | -39.5% | -36.8% |
| P/E (TTM) | -4.3 | -2.7 |
| P/B | 1.7 | 5.8 |
| P/E percentile vs own 5y | 25th | 91st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -92.4% | -27.7% |
| Net profit growth (YoY) | -13,319.5% | -169.3% |
| Gross margin | – | 16.4% |
| Operating margin | -476.2% | -80.4% |
| Net margin | -435.2% | -110.3% |
| Return on equity | -37.8% | -117.8% |
| Analyst target vs. price | +493.6% | +148.1% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 41 | 45 |
| 30-day volatility | 67.9% | 51.4% |
| Max drawdown, 1 year | -68.3% | -60.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VALN is the largest of the group by market value.
- VALN has returned the most over the past year.
- CTMX carries the lowest trailing P/E.
- VALN is growing revenue fastest.
- VALN keeps the most profit per dollar of sales.
- VALN has been the calmest stock over the last 30 days.